Trump signs psychedelic research order

The administration's initiative has sparked debate among medical professionals regarding the safety and long-term benefits of these substances.

Trump credited podcaster Joe Rogan for bringing the potential of drugs like ibogaine to his attention.

Proponents argue that psychedelics could provide a lifeline for patients who have not responded to conventional medicine.

However, critics warn that a rushed approval process could overlook critical risks associated with hallucinogenic treatments.